Phase II study of preoperative TS-1+CDDP therapy for advanced gastric cancer (OGSG 0004)
Phase 2
- Conditions
- Patients with unresectable gastric cancer due to limited inavasion or metastasis.
- Registration Number
- JPRN-UMIN000000934
- Lead Sponsor
- OGSG
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 30
Inclusion Criteria
Not provided
Exclusion Criteria
1) Under fresh bleeding from digestive tract 2) Patient who cannot take anticancer medicine orally due to gastrointestinal stenosis. 3) Type 4 gastric cancer 4) history of severe allergy against drug 5) under watery diarrhea 6) with sever disease on important organs (Infection, interstitial pneumonitis, pulmonary fibrosis, cardiac disease, renal dysfunction, liver dysfunction, DM controlled by insulin) 7) double cancer without carcinoma in citu 8) pregnant women or women who like to be pregnant 9) doctor' s dicision not to be registered to this study
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Response Rate(RECIST), probability on completion
- Secondary Outcome Measures
Name Time Method Overall Survival, Resectability, Recurrence Mode